Thread by @rhyscohen

1/ I want to draw your attention to a great #cannabis #business #intelligence report just released from @FreshleafA which is free to download. Disclosure: they’re a past client of mine, but I wouldn’t promote this report if it wasn’t awesome freshleafanalytics.com.au

2/ The best part of this analysis is it’s based on proprietary data taken from the largest chain of cannabis clinics in #Australia. So, although the patient access data I publish is more comprehensive, theirs is more precise. Here are the highlights:

3/ Counting active patients in Australia is diff-i-cult. Freshleaf’s definition is anyone seeing a clinic #doctor, receiving a script or receiving a new or replacement approval. My preferred definition is anyone in possession of an active recommendation but here's their graph

4/ It may surprise you that Australia has a wide range of products available for patients. These are all #GMP-compliant products which are almost exclusively imported. As of Q3 2019, there are 76 different products available. Pretty cool.

5/ What are these products exactly? Well there’s no formal restriction on product type in Australia, although the market is heavily skewed towards #oils and #capsules (~75% market share combined).

6/ About 1/3rd of prescribed products in Australia are pure-#CBD. Just over half are a CBD:THC combo, with pure-#THC and ‘others’ (most likely THCA/CBDA-containing) making up the remainder.

7/ #Price remains a big issue in Australia, and cannabis companies can’t publicly disclose the prices of their products due to advertising regulations. But Freshleaf show there is a huge spectrum of prices, from the reasonable to the ridiculous

8/ But those prices above are what the pharmacies pay drug providers. Then they add a mark-up (Freshleaf estimates an average of +22%). What people end up paying is heavily determined by their condition. #Epilepsy patients on average pay $50/day while others average $5-10/day

9/ How does this compare to #Canadian prices? Freshleaf compared the 5 cheapest Canadian and Australian products. The Canadian products were 16% cheaper on average. But that’s before factoring in the ~22% pharmacy mark-up so it’s actually more like a ~40% difference

10/ That's it for the highlights - don't forget to download and read the report yourself. It's probably the most detailed and useful market intelligence report you'll find on Australia. Enjoy!